Russia, Ukraine, Kazakhstan alter drug reimbursements

05/21/2013 | PharmaTimes (U.K.)

Russia, Ukraine and Kazakhstan are introducing new government drug-reimbursement plans that could dramatically alter the environment for the manufacture and sale of brand-name drugs and generics. Russia's strategy calls for new trade regulations, support for domestic manufacture and expanded drug reimbursements. Ukraine is seeking broader price controls of pharmaceuticals, including generics, and both Ukraine and Kazakhstan are expanding government programs for full or partial reimbursements for certain drugs.

View Full Article in:

PharmaTimes (U.K.)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Sr. Principal OptoMechanical Engineer - 14000008M2
Abbott
San Jose, CA
Director, Compliance - Health Plan Privacy & Security
Kaiser Permanente
Oakland, CA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC